Repository logo
  • AI Search Assistant Beta
    • English
    • 中文
    Log In
    Have you forgotten your password?
    1. Home
    2. College of Life Science / 生命科學院
    3. Life Science / 生命科學系
    4. Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment
     
    • Details

    Transcriptionally distinct malignant neuroblastoma populations show selective response to adavosertib treatment

    Journal
    Neurotherapeutics
    Start Page
    e00575
    ISSN
    1878-7479
    Date Issued
    2025-03-20
    Author(s)
    Chiao-Hui Hsieh
    Yi-Xuan Chen
    Tzu-Yang Tseng
    Albert Li
    Hsuan-Cheng Huang
    HSUEH-FEN JUAN  
    DOI
    10.1016/j.neurot.2025.e00575
    URI
    https://www.scopus.com/record/display.uri?eid=2-s2.0-105000694173&origin=resultslist
    https://scholars.lib.ntu.edu.tw/handle/123456789/726287
    Abstract
    Neuroblastoma is an aggressive childhood cancer that arises from the sympathetic nervous system. Despite advances in treatment, high-risk neuroblastoma remains difficult to manage due to its heterogeneous nature and frequent development of drug resistance. Drug repurposing guided by single-cell analysis presents a promising strategy for identifying new therapeutic options. Here, we aim to characterize high-risk neuroblastoma subpopulations and identify effective repurposed drugs for targeted treatment. We performed single-cell transcriptomic analysis of neuroblastoma samples, integrating bulk RNA-seq data deconvolution with clinical outcomes to define distinct malignant cell states. Using a systematic drug repurposing pipeline, we identified and validated potential therapeutic agents targeting specific high-risk neuroblastoma subpopulations. Single-cell analysis revealed 17 transcriptionally distinct neuroblastoma subpopulations. Survival analysis identified a highly aggressive subpopulation characterized by elevated UBE2C/PTTG1 expression and poor patient outcomes, distinct from a less aggressive subpopulation with favorable prognosis. Drug repurposing screening identified Adavosertib as particularly effective against the aggressive subpopulation, validated using SK-N-DZ cells as a representative model. Mechanistically, Adavosertib suppressed cell proliferation through AKT/mTOR pathway disruption, induced G2/M phase cell cycle arrest, and promoted apoptosis. Further analysis revealed UBE2C and PTTG1 as key molecular drivers of drug resistance, where their overexpression enhanced proliferation, Adavosertib resistance, and cell migration. This study establishes a single-cell-based drug repurposing strategy for high-risk neuroblastoma treatment. Our approach successfully identified Adavosertib as a promising repurposed therapeutic agent for targeting specific high-risk neuroblastoma subpopulations, providing a framework for developing more effective personalized treatment strategies.
    Subjects
    Adavosertib
    AKT/mTOR pathway
    Cancer therapy
    Neuroblastoma
    Single cell RNA sequencing
    SDGs

    [SDGs]SDG2

    [SDGs]SDG3

    Publisher
    Elsevier BV
    Type
    journal article

    臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

    To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

    總館學科館員 (Main Library)
    醫學圖書館學科館員 (Medical Library)
    社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

    開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

    • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
      Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
    • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
      Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
    • 網站簡介 (Quickstart Guide)
    • 使用手冊 (Instruction Manual)
    • 線上預約服務 (Booking Service)
    • 方案一:臺灣大學計算機中心帳號登入
      (With C&INC Email Account)
    • 方案二:ORCID帳號登入 (With ORCID)
    • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
    • 方案二:自行建檔 (Default mode Submission)
    • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

    Built with DSpace-CRIS software - Extension maintained and optimized by 4Science